References
- www.who.int [Internet]. London, Ontario: FAO and WHO; [updated 2014 Mar 18; cited 2002 May 1]. Available from: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
- Sotoudegan F, Daniali M, Hassani S, et al. Reappraisal of probiotics’ safety in human. Food Chem Toxicol. 2019;129:22–29.
- John GK, Mullin GE. The gut microbiome and obesity. Curr Oncol Rep. 2016;18(7):45.
- Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.
- Abenavoli L, Scarpellini E, Colica C, et al. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11(11):2690.
- Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027.
- Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One. 2016;11(5):e0154090.
- Turta O, Rautava S. Antibiotics, obesity and the link to microbes-what are we doing to our children? BMC Med. 2016;14(1):57.
- Del Chierico F, Vernocchi P, Dallapiccola B, et al. Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci. 2014;15(7):11678–11699.
- Salamati S, Martins C, Kulseng B. Baker’s yeast (S accharomyces cerevisiae) antigen in obese and normal weight subjects. Clin Obes. 2015;5(1):42–47.
- Reijnders D, Goossens G, Hermes D. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial. Cell Metab. 2016;24(1):63–74.
- Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–11075.
- Bäckhed F, Manchester JK, Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104(3):979–984.
- Collado MC, Surono IS, Meriluoto J, et al. Potential probiotic characteristics of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonization. J Food Prot. 2007;70(3):700–705.
- Bagarolli RA, Tobar N, Oliveira AG, et al. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. J Nutr Biochem. 2017;50:16–25.
- Ejtahed H-S, Angoorani P, Soroush A-R, et al. Probiotics supplementation for the obesity management; A systematic review of animal studies and clinical trials. J Funct Foods. 2019;52:228–242.
- Barengolts E. Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: review of randomized controlled trials. Endocr Pract. 2016;22(10):1224–1234.
- Chen L, Zou Y, Peng J, et al. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J Immunol Res. 2015;2015:1–10.
- Wang T, Yan H, Lu Y, et al. Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation. Eur J Nutr. 2019;1–20.
- Liu Q, Liu Y, Li F, et al. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. J Nutr Biochem. 2019. DOI:10.1016/j.jnutbio.2019.108256.